1Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vasucular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies[J ]. Lancet,2002,360(9349):1903 1913.
3Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker[J]. N Engl J Med, 2006,354(16):1685 -1697.
4Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for Management of Arterial Hypertension of the European Society of Hypertension (ESH)and of the European Society of Cardiology (ESC)[ J ]. Eur Heart J, 2007,28 (12) : 1462 -1536.
5Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial[J]. Lancet, 2004,363 (9426) : 2022 - 2031.
6Chobanian AV, Bakris GL, Black HR, et al. The seventh report of prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report [ J ]. JAMA, 2003,289 ( 19 ) : 2560 2572.
7Jamerson K,Weber MA,Bakris GL, et al. Benazepril plus amlodipine or hydrochloro thiazide for hypertension in high-risk patients [J]. N Engl J Med,2008,359(23) :2417- 2428.
8Romito R, Pansini MI, Perticone F, et al. Comparative effect of lercanidipine felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hepertension: the Lercanidipine in Adults(LEAD) Study [ J ]. J Clin Hypertens, 2003,5(4) :249 - 253.
9Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTTON trial ): randomised controlled trial[J ]. Lancet, 2004,364(9437 ) : 849 - 857.
10Yusue S, Hawken S, Ounpuu S, el al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries ( the INTERHEART study) : case-control study [ J ]. Lancet, 2004,364 (9438) : 937 - 952.
8Materson B J. Variability in response to antihypertensive drugs[J]. Am J Meal,2007,120(4 Suppll) :S10-20.
9Ileana L,Rebecca S,Douglas D,et al. Elderly patients are less to re- ceive evidence--based Medications indicated for systolic heart fail- ure:results from the study of anemia in a heart Failure population (stamina- hfp) registry[J]. JACC, 2010,55 (10A) : 309- 312.
10Paris A. Kosmidis,Meletios-Athanasios Dimopoulos,Konstantinos Syrigos,Costas Nicolaides,Gerasimos Aravantinos,Ioannis Boukovinas,Dimitrios Pectasides,George Fountzilas,Dimitrios Bafaloukos,Charalampos Bacoyiannis,Haralampos P. Kalofonos.Gemcitabine versus Gemcitabine–Carboplatin for Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: A Prospective Randomized Phase II Study of the Hellenic Cooperative Oncology Group[J]. Journal of Thoracic Oncology . 2007 (2)
